BET bromodomain proteins regulate enhancer function during adipogenesis
Developmental transitions are guided by master regulatory transcription factors. During adipogenesis, a transcriptional cascade culminates in the expression of PPARγ and C/EBPα, which orchestrate activation of the adipocyte gene expression program. However, the coactivators controlling PPARγ and C/E...
Main Authors: | Brown, Jonathan D., Feldman, Zachary B., Doherty, Sean P., Reyes, Jaime M., Rahl, Peter B., Lin, Charles Y., Sheng, Quanhu, Duan, Qiong, Federation, Alexander J., Kung, Andrew L., Haldar, Saptarsi M., Plutzky, Jorge, Bradner, James E., Young, Richard A. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Published: |
National Academy of Sciences (U.S.)
2018
|
Online Access: | http://hdl.handle.net/1721.1/118467 https://orcid.org/0000-0001-8855-8647 |
Similar Items
-
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
by: Delmore, Jake E., et al.
Published: (2014) -
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
by: Shu, Shaokun, et al.
Published: (2017) -
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
by: Bandopadhayay, Pratiti, et al.
Published: (2020) -
Engineered bromodomains to explore the acetylproteome
by: Del Rosario, Amanda M, et al.
Published: (2016) -
Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington’s disease mice
by: Kedaigle, Amanda J, et al.
Published: (2020)